Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018551 · ClinicalTrials.gov registry record · Phase 2
Chemoprevention With Folic Acid
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00018551 is a Phase 2 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018551, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
Colorectal neoplasia is the second most common cancer in the United States and other Western countries with about 140,000 newly diagnosed cases per year in the United States with a mortality rate of about 40%. The identification of a specific natural or synthetic compound with the ability to reverse or suppress the process of colon carcinogenesis would have profound implication in the development of colorectal adenomas and their subsequent transformation to colon cancer. Furthermore, the establishment of a correlative relationship between biomarkers of cell proliferation, differentiation, apoptosis and adenoma recurrence would provide pivotal data required to elucidate cell signaling mechanisms in future colon cancer chemoprevention trials.
Interventions
- DRUG Folic Acid
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-10 |
| Est. Completion | 2003-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018551
The ClinicalTrials.gov registry entry for NCT00018551 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Folic Acid is the first listed.
NCT00018551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018551 about?
NCT00018551 is a clinical study titled "Chemoprevention With Folic Acid". Colorectal neoplasia is the second most common cancer in the United States and other Western countries with about 140,000 newly diagnosed cases per year in the United States with a mortality rate of about 40%. The identification of a specific natural or synthetic compound with the ability to reverse...
What is the current status of trial NCT00018551?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-10. Estimated completion is 2003-09.
What interventions are being tested in trial NCT00018551?
The interventions under investigation include: Folic Acid (DRUG).
Who is sponsoring clinical trial NCT00018551?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.